{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:59:18Z","timestamp":1783961958713,"version":"3.55.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,23]]},"abstract":"<jats:p>Although some studies have reported prognostic factors for coronavirus disease 2019 (COVID-19), they were conducted before standard treatment with remdesivir and dexamethasone was implemented. This retrospective, observational study was conducted to evaluate various prognostic factors in patients with COVID-19 pneumonia receiving standard treatment with remdesivir and dexamethasone. Of 99 patients with COVID-19 pneumonia, 68 (68.7%) died within 30 days of hospitalization. The mean age was 71.3 years. Remdesivir and dexamethasone were administered to 80 (80.8%) and 84 (84.8%) patients, respectively. Early antibiotic treatment was administered to 70 patients (70.7%) within 5 days of hospitalization. Dexamethasone (79.4% vs 96.8%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.033) was more frequently administered in the survived group, whereas early antibiotics (60.3% vs 93.5%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.001) were less frequently administered. In the multivariate analysis, a high National Early Warning Score (NEWS; odds ratio [OR] 1.272), high Charlson Comorbidity Index (CCI; OR 1.441), and dyspnea (OR 4.033) were independent risk factors for 30-day mortality. There was no significant difference in age, sex, and vaccination doses between the survived and fatal groups. Lymphopenia, monocytopenia and high levels of C-reactive protein (CRP)\/lactate dehydrogenase (LDH) reflected poor prognosis. NEWS, CCI, and dyspnea were predictors of 30-day mortality in patients with COVID-19 pneumonia. Early antibiotic use did not lower the 30-day mortality risk.<\/jats:p>","DOI":"10.1097\/md.0000000000030474","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T14:08:56Z","timestamp":1663942136000},"page":"e30474","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic factors of 30-day mortality in patients with COVID-19 pneumonia under standard remdesivir and dexamethasone treatment"],"prefix":"10.1097","volume":"101","author":[{"given":"Yu Jung","family":"Choi","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Young","family":"Song","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakjun","family":"Hyun","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliel","family":"Nham","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Gu","family":"Yoon","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye","family":"Seong","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yun","family":"Noh","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Cheong","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Joo","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of Coronavirus disease 2019 in China.","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jiph.2021.11.012","article-title":"Risk factors for COVID-19 progression and mortality in hospitalized patients without pre-existing comorbidities.","volume":"15","author":"Liu","year":"2022","journal-title":"J Infect Public Health"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"e0256744","DOI":"10.1371\/journal.pone.0256744","article-title":"D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19.","volume":"16","author":"Poudel","year":"2021","journal-title":"PLoS One"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s12603-021-1690-7","article-title":"Hypercalcemia as a biomarker of poor prognosis in frail elderly patients with COVID-19.","volume":"25","author":"Pamart","year":"2021","journal-title":"J Nutr Health Aging"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"e4039","DOI":"10.1093\/cid\/ciaa1258","article-title":"Reduced vitamin K status as a potentially modifiable risk factor of severe Coronavirus disease 2019.","volume":"73","author":"Dofferhoff","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/idr13040085","article-title":"Prognostic role of anemia in COVID-19 patients: a meta-analysis.","volume":"13","author":"Zuin","year":"2021","journal-title":"Infect Dis Rep"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.dsx.2020.10.022","article-title":"Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: a systematic review and meta-analysis.","volume":"14","author":"Tuty Kuswardhani","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.resuscitation.2010.04.014","article-title":"ViEWS--towards a National Early Warning Score for detecting adult inpatient deterioration.","volume":"81","author":"Prytherch","year":"2010","journal-title":"Resuscitation"},{"key":"R12-20250504","first-page":"505","article-title":"Status and characteristics of the SARSCoV-2 variant outbreak in the Republic of Korea in January 2021.","volume":"15","author":"Kim","year":"2022","journal-title":"Pub Health Week Rep"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","article-title":"Severe outcomes among patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.","volume":"69","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmi.2020.09.041","article-title":"Recommendations for antibacterial therapy in adults with COVID-19\u2014an evidence based guideline.","volume":"27","author":"Sieswerda","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/cancers13030471","article-title":"Lymphopenia as a biological predictor of outcomes in COVID-19 patients: a nationwide cohort study.","volume":"13","author":"Lee","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1002\/jmv.26061","article-title":"Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: a retrospective cross-sectional study.","volume":"92","author":"Yan","year":"2020","journal-title":"J Med Virol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/archinternmed.2009.55","article-title":"Red blood cell distribution width and mortality risk in a community-based prospective cohort.","volume":"169","author":"Perlstein","year":"2009","journal-title":"Arch Intern Med"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/CCM.0b013e31821b85c6","article-title":"Red cell distribution width and all-cause mortality in critically ill patients.","volume":"39","author":"Bazick","year":"2011","journal-title":"Crit Care Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ajem.2012.10.017","article-title":"Red cell distribution width is a prognostic factor in severe sepsis and septic shock.","volume":"31","author":"Jo","year":"2013","journal-title":"Am J Emerg Med"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10654-020-00678-5","article-title":"Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis.","volume":"35","author":"Taneri","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2146","article-title":"Predictors of COVID-19 severity: a literature review.","volume":"31","author":"Gallo Marin","year":"2021","journal-title":"Rev Med Virol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2020.06.012","article-title":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.","volume":"509","author":"Poggiali","year":"2020","journal-title":"Clin Chim Acta"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ije\/dyab012","article-title":"The role of C-reactive protein as a prognostic marker in COVID-19.","volume":"50","author":"Stringer","year":"2021","journal-title":"Int J Epidemiol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.clnesp.2020.09.018","article-title":"Prevalence and severity of malnutrition in hospitalized COVID-19 patients.","volume":"40","author":"Bedock","year":"2020","journal-title":"Clin Nutr ESPEN"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00392-020-01683-0","article-title":"Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection.","volume":"109","author":"Rath","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"n1088","DOI":"10.1136\/bmj.n1088","article-title":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.","volume":"373","author":"Lopez Bernal","year":"2021","journal-title":"BMJ"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1001\/jama.2021.19499","article-title":"Association between mRNA vaccination and COVID-19 hospitalization and disease severity.","volume":"326","author":"Tenforde","year":"2021","journal-title":"JAMA"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:20:32Z","timestamp":1746336032000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":27,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030474","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]}}}